X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor Cancer
- Interventions
- Combination Product: X-PACT
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Immunolight, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04389281
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸Sibley Hospital - Johns Hopkins University, Washington, District of Columbia, United States
🇺🇸Levine Cancer Institute, Charlotte, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath